SCHEMBL7835082

SCHEMBL7835082

Cc1ccc(OCC(C)C)c2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 5/20 0.48
▸ ALDH1A1 P00352 3/20 0.43
▸ GAA P10253 1/20 0.43
▸ CYP2D6 P10635 5/20 0.41
▸ TLR8 Q9NR97 1/20 0.41
▸ SLC2A1 P11166 1/20 0.40
▸ NR2E1 Q9Y466 2/20 0.40
▸ DHODH Q02127 1/20 0.39
▸ ELANE P08246 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ CYP2A6 P11509 1/20 0.38
▸ HTR2C P28335 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ ADRB2 P07550 1/20 0.38
▸ ADRB1 P08588 1/20 0.38
▸ ADRB3 P13945 1/20 0.38
▸ HTR1B P28222 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ SLC6A4 P31645 1/20 0.38
▸ SCN1A P35498 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17912799 0.90 ALDH1A1 (0.50) CYP1A2ALDH1A1GAACYP2D6TLR8
SCHEMBL31599179 0.90 ALDH1A1 (0.50) CYP1A2ALDH1A1GAACYP2D6TLR8
SCHEMBL6123816 0.83 IDO1 (0.50) CYP1A2ALDH1A1GAACYP2D6TLR8
SCHEMBL2023749 0.80 IDO1 (0.59) CYP1A2ALDH1A1GAACYP2D6TLR8
SCHEMBL7835080 0.80 ALDH1A1 (0.42) CYP1A2ALDH1A1GAACYP2D6TLR8
SCHEMBL8229480 0.79 CYP1A2 (0.54) CYP1A2ALDH1A1GAAKDM4ECYP2A6
SCHEMBL9330168 0.77 CYP2D6 (0.72) CYP1A2ALDH1A1CYP2D6NR2E1HTR2C
SCHEMBL28680549 0.77 CYP2D6 (0.72) CYP1A2ALDH1A1CYP2D6NR2E1HTR2C
SCHEMBL30001770 0.77 CYP2D6 (0.72) CYP1A2ALDH1A1CYP2D6NR2E1HTR2C
SCHEMBL17299161 0.77 CYP1A2 (0.52) CYP1A2ALDH1A1CYP2D6KDM4ECYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 — — EP disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 — — US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 — — EP disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 — — US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 — — US disclosed
US-5886014-A TREATMENT AND/OR PROPHYLAXIS OF A VARIETY OF DISORDERS, INCLUDING HYPERLIPEMIA, HYPERGLYCEMIA, OBESITY, IMPAIRED GLUCOSE TOLERANCE (IGT), INSULIN RESISTANCE AND DIABETIC COMPLICATIONS SANKYO COMPANY, LIMITED (JP) 1999-03-23 — — US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 — — US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 — — US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 — — US disclosed
EP-0745600-A1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-12-04 — — EP disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 — — EP disclosed
Send feedback